STOER For Men with CBD oil

STOER For Men with CBD oil

Labskin CBD tests show greater than 99% reduction in bacterial growth on human skinIntegumen plc (AIM: SKIN) is pleased to announce a greater than 99% reduction of bacterial growth in preliminary results of four formulations, all of which include Cannabinoid (CBD)...

TSpro disposal removes £1.19m liabilities

TSpro disposal removes £1.19m liabilities

Divestment of TSPro GmbH to remove c€1.34m (£1.19m) of short and long term liabilities from Integumen Today the Company announces the divestment (“Disposal”) of TSpro GmbH (“TSPro”), a wholly-owned subsidiary of Integumen plc. The Company has entered into a...

Labskin On A Chip

Labskin On A Chip

Labskin-On-A-Chip to monitor real-time skin related diseases and Labskin-AI data analysis to predict the best course of treatmentIntegumen is pleased to announce a cross-platform biophysics agreement with AI developer, Rinocloud Limited, in association with Cork...

Artificially Intelligent Labskin

Artificially Intelligent Labskin

First laboratory-grown human-skin test service, to use artificial intelligence, to provide clinical validation for cosmetic, personal hygiene and skin care products. Labskin (Innovenn Ltd.), a wholly-owned subsidiary of Integumen plc., (AIM:SKIN) today announces that...

Share This